 Quality of Life
"Quality of Life" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease.
| Descriptor ID |
D011788
|
| MeSH Number(s) |
I01.800 K01.752.400.750 N06.850.505.400.425.837
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Quality of Life".
Below are MeSH descriptors whose meaning is more specific than "Quality of Life".
This graph shows the total number of publications written about "Quality of Life" by people in this website by year, and whether "Quality of Life" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 | | 1995 | 1 | 1 | 2 | | 1996 | 3 | 9 | 12 | | 1997 | 4 | 6 | 10 | | 1998 | 3 | 4 | 7 | | 1999 | 6 | 9 | 15 | | 2000 | 3 | 4 | 7 | | 2001 | 3 | 5 | 8 | | 2002 | 5 | 5 | 10 | | 2003 | 12 | 17 | 29 | | 2004 | 8 | 12 | 20 | | 2005 | 16 | 17 | 33 | | 2006 | 17 | 21 | 38 | | 2007 | 16 | 16 | 32 | | 2008 | 16 | 22 | 38 | | 2009 | 21 | 29 | 50 | | 2010 | 27 | 34 | 61 | | 2011 | 18 | 34 | 52 | | 2012 | 26 | 33 | 59 | | 2013 | 28 | 34 | 62 | | 2014 | 34 | 46 | 80 | | 2015 | 37 | 44 | 81 | | 2016 | 45 | 55 | 100 | | 2017 | 42 | 51 | 93 | | 2018 | 55 | 83 | 138 | | 2019 | 69 | 71 | 140 | | 2020 | 60 | 81 | 141 | | 2021 | 33 | 97 | 130 | | 2022 | 27 | 130 | 157 | | 2023 | 33 | 123 | 156 | | 2024 | 6 | 22 | 28 |
To return to the timeline, click here.
Below are the most recent publications written about "Quality of Life" by people in Profiles.
-
Anagnostou A, Greenhawt M, Rodriguez Del R?o P, Pickett G, Szafron V, Stukus D, Abrams EM. Addressing common questions on food oral immunotherapy: a practical guide for paediatricians. Arch Dis Child. 2024 08 16; 109(9):697-701.
-
Shivakumar N, King AA, Lyons KD, L'Hotta AJ. "If I have a limited amount of time left, this is not how I want to spend it": A qualitative descriptive study of factors influencing daily life participation following a cancer diagnosis. Psychooncology. 2024 Jun; 33(6):e6366.
-
Kubicki T, Jamroziak K, Robak P, Czyz J, Tyczynska A, Druzd-Sitek A, Giannopoulos K, Wr?bel T, Nowicki A, Szczepaniak T, Lojko-Dankowska A, Matuszak M, Gil L, Pula B, Szukalski L, Konska A, Zaucha JM, Walewski J, Mikulski D, Czabak O, Robak T, Kruk-Kwapisz D, Derman BA, Major A, Jakubowiak AJ, Dytfeld D. Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone. Pol Arch Intern Med. 2024 05 28; 134(5).
-
Mart MF, Boehm LM, Kiehl AL, Gong MN, Malhotra A, Owens RL, Khan BA, Pisani MA, Schmidt GA, Hite RD, Exline MC, Carson SS, Hough CL, Rock P, Douglas IS, Feinstein DJ, Hyzy RC, Schweickert WD, Bowton DL, Masica A, Orun OM, Raman R, Pun BT, Strength C, Rolfsen ML, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Ely EW, Jackson JC, Girard TD. Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2024 Aug; 12(8):599-607.
-
Carl A, Good M, Haag E, Hutaff-Lee C, Swain D, Tartaglia N, Sakamoto C, Davis S, Thompson T. Anxiety in Turner syndrome: Engaging community to address barriers and facilitators to diagnosis and care. Am J Med Genet A. 2024 08; 194(8):e63564.
-
Raghu G, Ghazipura M, Fleming TR, Aronson KI, Behr J, Brown KK, Flaherty KR, Kazerooni EA, Maher TM, Richeldi L, Lasky JA, Swigris JJ, Busch R, Garrard L, Ahn DH, Li J, Puthawala K, Rodal G, Seymour S, Weir N, Danoff SK, Ettinger N, Goldin J, Glassberg MK, Kawano-Dourado L, Khalil N, Lancaster L, Lynch DA, Mageto Y, Noth I, Shore JE, Wijsenbeek M, Brown R, Grogan D, Ivey D, Golinska P, Karimi-Shah B, Martinez FJ. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency. Am J Respir Crit Care Med. 2024 03 15; 209(6):647-669.
-
Herman D, Ghazipura M, Barnes H, Macrea M, Knight SL, Silver RM, Montesi SB, Raghu G, Hossain T. Nintedanib Therapy Alone and Combined with Mycophenolate in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: Systematic Reviews and Meta-analysis. Ann Am Thorac Soc. 2024 Mar; 21(3):474-485.
-
Judd DL, Cheuy V, Peters A, Graber J, Hinrichs-Kinney L, Forster JE, Christiansen CL, Stevens-Lapsley JE. Incorporating Functional Strength Integration Techniques During Total Hip Arthroplasty Rehabilitation: A Randomized Controlled Trial. Phys Ther. 2024 Mar 01; 104(3).
-
Rosenthal SL, Simpson TS, Kirkwood M, Peterson RL. Quality of Life in Youth Soccer Players After Mild Traumatic Brain Injury. J Athl Train. 2024 Feb 01; 59(2):130-136.
-
Macrea M, Ghazipura M, Herman D, Barnes H, Knight SL, Silver RM, Montesi SB, Raghu G, Hossain T. Rituximab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2024 Feb; 21(2):317-327.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|